Rubric Capital Management
Latest statistics and disclosures from Rubric Capital Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are TLN, TEVA, GLNG, ROIV, VST, and represent 50.37% of Rubric Capital Management's stock portfolio.
- Added to shares of these 10 stocks: TLN (+$2.0B), VST (+$95M), UAL (+$64M), THS (+$48M), DK (+$38M), QDEL (+$25M), ALIT (+$24M), EMBC (+$15M), ARQT (+$11M), SDGR (+$10M).
- Started 9 new stock positions in ZVRA, UAL, TLN, THS, Seaport Entmt Group, EMBC, IART, DK, Seaport Entmt Group Inc Rt Exp 101024.
- Reduced shares in these 10 stocks: , PLAY (-$49M), COOP (-$45M), , COLL (-$42M), CSTM (-$35M), ANIP (-$33M), TEVA (-$23M), FLR (-$21M), EXTR (-$20M).
- Sold out of its positions in BCYC, CRS, PLAY, IMVT, KOP, VYX, PTGX, RVNC, SSTK, SPRY. JAZZ, PLYA.
- Rubric Capital Management was a net buyer of stock by $1.9B.
- Rubric Capital Management has $6.1B in assets under management (AUM), dropping by 60.91%.
- Central Index Key (CIK): 0001687509
Tip: Access up to 7 years of quarterly data
Positions held by Rubric Capital Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Rubric Capital Management
Rubric Capital Management holds 64 positions in its portfolio as reported in the September 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Talen Energy Corp (TLN) | 33.0 | $2.0B | NEW | 11M | 178.24 |
|
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 4.7 | $288M | -7% | 16M | 18.02 |
|
| Golar Lng SHS Call Option (GLNG) | 4.3 | $266M | 7.2M | 36.76 |
|
|
| Roivant Sciences SHS (ROIV) | 4.2 | $259M | -2% | 22M | 11.54 |
|
| Vistra Energy (VST) | 4.1 | $252M | +60% | 2.1M | 118.54 |
|
| Viatris (VTRS) | 3.8 | $234M | 20M | 11.61 |
|
|
| Quidel Corp (QDEL) | 3.1 | $192M | +15% | 4.2M | 45.60 |
|
| Bgc Group Cl A (BGC) | 2.5 | $156M | -10% | 17M | 9.18 |
|
| Fluor Corporation (FLR) | 2.2 | $133M | -13% | 2.8M | 47.71 |
|
| Liberty Global Com Cl A (LBTYA) | 1.9 | $117M | 5.5M | 21.11 |
|
|
| Arcutis Biotherapeutics (ARQT) | 1.7 | $102M | +11% | 11M | 9.30 |
|
| Mednax (MD) | 1.6 | $96M | 8.3M | 11.59 |
|
|
| Mr Cooper Group (COOP) | 1.6 | $96M | -31% | 1.0M | 92.18 |
|
| Amneal Pharmaceuticals Com Stk Cl A (AMRX) | 1.5 | $89M | 11M | 8.32 |
|
|
| Renew Energy Global Cl A Shs (RNW) | 1.4 | $86M | 14M | 6.29 |
|
|
| Alight Com Cl A (ALIT) | 1.4 | $86M | +38% | 12M | 7.40 |
|
| Dole Ord Shs (DOLE) | 1.4 | $84M | 5.1M | 16.29 |
|
|
| Liberty Global Com Cl C (LBTYK) | 1.2 | $76M | 3.5M | 21.61 |
|
|
| Adaptive Biotechnologies Cor (ADPT) | 1.2 | $74M | +2% | 14M | 5.12 |
|
| Opko Health (OPK) | 1.2 | $73M | +9% | 49M | 1.49 |
|
| Schrodinger (SDGR) | 1.1 | $68M | +17% | 3.7M | 18.55 |
|
| Schweitzer-Mauduit International (MATV) | 1.1 | $68M | 4.0M | 16.99 |
|
|
| Pactiv Evergreen (PTVE) | 1.1 | $66M | 5.7M | 11.51 |
|
|
| Hldgs (UAL) | 1.0 | $64M | NEW | 1.1M | 57.06 |
|
| Mereo Biopharma Group Spon Ads (MREO) | 1.0 | $63M | 15M | 4.11 |
|
|
| Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA) | 1.0 | $61M | 2.4M | 24.99 |
|
|
| Extreme Networks (EXTR) | 1.0 | $59M | -25% | 3.9M | 15.03 |
|
| Avis Budget (CAR) | 1.0 | $59M | -2% | 672k | 87.59 |
|
| Transalta Corp (TAC) | 0.9 | $58M | +19% | 5.6M | 10.36 |
|
| Orthofix Medical (OFIX) | 0.9 | $58M | 3.7M | 15.62 |
|
|
| Adeia (ADEA) | 0.9 | $55M | 4.6M | 11.91 |
|
|
| Heron Therapeutics (HRTX) | 0.9 | $53M | 27M | 1.99 |
|
|
| Stratasys SHS (SSYS) | 0.8 | $51M | +3% | 6.2M | 8.31 |
|
| Zymeworks Del (ZYME) | 0.8 | $49M | 3.9M | 12.55 |
|
|
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 0.8 | $48M | -46% | 1.3M | 38.64 |
|
| TreeHouse Foods (THS) | 0.8 | $48M | NEW | 1.1M | 41.98 |
|
| Xperi Common Stock (XPER) | 0.6 | $38M | 4.1M | 9.24 |
|
|
| Teladoc (TDOC) | 0.6 | $38M | -10% | 4.1M | 9.18 |
|
| Delek Us Holdings (DK) | 0.6 | $38M | NEW | 2.0M | 18.75 |
|
| Goodrx Hldgs Com Cl A (GDRX) | 0.5 | $33M | +25% | 4.7M | 6.94 |
|
| Aar (AIR) | 0.5 | $31M | -17% | 472k | 65.36 |
|
| Ftai Infrastructure Common Stock (FIP) | 0.5 | $30M | 3.2M | 9.36 |
|
|
| Cannae Holdings (CNNE) | 0.4 | $27M | 1.4M | 19.06 |
|
|
| Constellium Se Cl A Shs (CSTM) | 0.4 | $25M | -58% | 1.5M | 16.26 |
|
| Scpharmaceuticals (SCPH) | 0.4 | $22M | +35% | 4.8M | 4.56 |
|
| Ardelyx (ARDX) | 0.3 | $21M | +68% | 3.1M | 6.89 |
|
| Trevi Therapeutics (TRVI) | 0.3 | $17M | 5.0M | 3.34 |
|
|
| Riskified Shs Cl A (RSKD) | 0.3 | $16M | -19% | 3.4M | 4.73 |
|
| Embecta Corp Common Stock (EMBC) | 0.2 | $15M | NEW | 1.1M | 14.10 |
|
| Telesat Corp Cl A & Cl B Shs (TSAT) | 0.2 | $13M | 960k | 13.17 |
|
|
| Omniab (OABI) | 0.2 | $12M | 2.9M | 4.23 |
|
|
| Coherus Biosciences (CHRS) | 0.2 | $11M | 10M | 1.04 |
|
|
| Seaport Entmt Group Common Stock | 0.1 | $7.6M | NEW | 277k | 27.42 |
|
| Arbutus Biopharma (ABUS) | 0.1 | $6.5M | 1.7M | 3.85 |
|
|
| Ovid Therapeutics (OVID) | 0.1 | $6.3M | 5.3M | 1.18 |
|
|
| Integra Lifesciences Hldgs C Com New (IART) | 0.1 | $5.3M | NEW | 293k | 18.17 |
|
| Playstudios Class A Com (MYPS) | 0.1 | $4.1M | 2.7M | 1.51 |
|
|
| Biosante Pharmaceuticals (ANIP) | 0.1 | $3.4M | -90% | 57k | 59.66 |
|
| Werewolf Therapeutics (HOWL) | 0.0 | $2.8M | 1.3M | 2.12 |
|
|
| Therapeuticsmd Com New (TXMD) | 0.0 | $2.0M | 1.2M | 1.66 |
|
|
| Coherus Biosciences Note 1.500% 4/1 (Principal) | 0.0 | $1.9M | 2.5M | 0.78 |
|
|
| Seaport Entmt Group Right 10/10/2024 | 0.0 | $427k | NEW | 145k | 2.95 |
|
| Zevra Therapeutics Com New (ZVRA) | 0.0 | $139k | NEW | 20k | 6.94 |
|
| Vincerx Pharma Com New (VINC) | 0.0 | $84k | 117k | 0.72 |
|
Past Filings by Rubric Capital Management
SEC 13F filings are viewable for Rubric Capital Management going back to 2016
- Rubric Capital Management 2024 Q3 filed Nov. 13, 2024
- Rubric Capital Management 2024 Q2 filed Aug. 13, 2024
- Rubric Capital Management 2024 Q1 filed May 10, 2024
- Rubric Capital Management 2023 Q3 restated filed Nov. 15, 2023
- Rubric Capital Management 2023 Q3 filed Nov. 14, 2023
- Rubric Capital Management 2023 Q2 filed Aug. 11, 2023
- Rubric Capital Management 2023 Q1 filed May 12, 2023
- Rubric Capital Management 2022 Q4 filed Feb. 10, 2023
- Rubric Capital Management 2022 Q3 filed Nov. 14, 2022
- Rubric Capital Management 2022 Q2 restated filed Aug. 15, 2022
- Rubric Capital Management 2022 Q2 filed Aug. 12, 2022
- Rubric Capital Management 2022 Q1 filed May 13, 2022
- Rubric Capital Management 2021 Q4 filed Feb. 14, 2022
- Rubric Capital Management 2021 Q3 filed Nov. 12, 2021
- Rubric Capital Management 2021 Q2 filed Aug. 13, 2021
- Rubric Capital Management 2021 Q1 filed May 14, 2021